Sufang Shi

9PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 31, 2026
Glucocorticoid-Modulated Molecular Signatures and Prediction of Treatment Efficacy in IgA Nephropathy.

|Apr 08, 2026
Endothelin Receptor Antagonist Ambrisentan, Sodium-Glucose Cotransporter 2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy: A Randomized Crossover Trial.

Qinlan Chen, Pei Chen, Lijun Liu

|Jan 21, 2026
Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Lin-Lin Xu, Xu-Jie Zhou, Wenjian Bi

|Jan 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.

Sean J Barbour, Rosanna Coppo, Lee Er

|Aug 31, 2023
Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.

Yuqi Kang, Boyang Xu, Sufang Shi

Pageof 2

Frequent Collaborators

6 joint publications

Lijun Liu

5 joint publications

Xujie Zhou

3 joint publications

Jinwei Wang

3 joint publications

MuhGeot Wong